v3.25.2
Schedule of condensed statements of cash flows (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:          
Net loss $ (4,674,358) $ (3,034,984) $ (39,475,321) $ (15,306,550)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization of discount on convertible bonds     807,860  
Unrealized foreign exchange gain 328,269 (124,690) (659,467) (65,981)  
Changes in operating assets and liabilities:          
Prepayments, deposits and other receivables (4,918,772) 9,477,057 7,980,401 2,502,972  
Net cash (used in)/provided by operating activities (1,487,912) (220,972) 3,450,240 (15,286,494)  
Cash flows from investing activities:          
Net cash provided by/(used in) investing activities (174,562) (11,443) (565,034) 1,444,823  
Cash flows from financing activities:          
Proceeds from borrowings 639,210 640,935 1,251,752  
Repayment of borrowings (95,742) (221,258) (2,212,067)  
Net cash used in financing activities 141,611 470,451 2,016,549 (1,197,648)  
Net (decrease)/increase in cash and cash equivalents $ (1,520,863) 238,036 4,901,755 (15,039,319)  
Seamless Group Inc [Member]          
Cash flows from operating activities:          
Net loss       (15,306,550) $ (16,678,135)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization of discount on convertible bonds       807,860 3,438,950 [1]
Unrealized foreign exchange gain       (65,981) 543,277 [1]
Changes in operating assets and liabilities:          
Prepayments, deposits and other receivables       2,502,972 (5,796,690) [1]
Net cash (used in)/provided by operating activities       (15,286,494) 8,681,916 [1]
Cash flows from investing activities:          
Net cash provided by/(used in) investing activities       1,444,823 (732,332) [1]
Cash flows from financing activities:          
Proceeds from borrowings       1,251,752 1,481,263 [1]
Repayment of borrowings       (2,212,067) (2,242,961) [1]
Repayment of convertible bonds       (3,500,000) [1]
Net cash used in financing activities       (1,197,648) (5,767,020) [1]
Net (decrease)/increase in cash and cash equivalents       (15,039,319) 2,182,564 [1]
Parent Company [Member] | Seamless Group Inc [Member]          
Cash flows from operating activities:          
Net loss       (15,306,550) (16,678,134)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization of discount on convertible bonds       807,861 3,438,951
Unrealized foreign exchange gain       23,008 (644)
Share of results from subsidiaries       5,787,749 4,234,448
Changes in operating assets and liabilities:          
Prepayments, deposits and other receivables       (30,862) (9,900)
Accruals and other payables       4,206,601 3,797,118
Net cash (used in)/provided by operating activities       (4,512,193) (5,218,161)
Cash flows from investing activities:          
Dividend received from a subsidiary       2,847,309
(Increase) decrease in short-term investments       2,012,562
Cash injected into a subsidiary       (2,012,562)
Net cash provided by/(used in) investing activities       2,847,309
Cash flows from financing activities:          
Proceeds from borrowings       1,251,752 2,758,213
Repayment of borrowings       (1,663,042) (1,276,950)
Repayment of convertible bonds       (3,483,133)
Amounts due from related parties       691,323 301,958
Amounts due to related parties       4,283,780 4,123,866
Net cash used in financing activities       4,563,813 2,423,954
Net (decrease)/increase in cash and cash equivalents       51,620 53,102
Effect of exchange rate changes on cash and cash equivalents       46 218
Cash and cash equivalents at beginning of year   $ 130,634 $ 130,634 78,968 25,648
Cash and cash equivalents at end of year       $ 130,634 $ 78,968
[1] Periods presented have been adjusted. Additional information regarding the adjustment may be found in Note 3 - Restatement of Previously Issued Financial Statements, included elsewhere in the notes to the financial statements.